• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

使用计算机控制的搅拌罐生物反应器生产用于过继性免疫疗法的人类自然杀伤细胞。

Production of human natural killer cells for adoptive immunotherapy using a computer-controlled stirred-tank bioreactor.

作者信息

Pierson B A, Europa A F, Hu W S, Miller J S

机构信息

Department of Chemical Engineering and Materials Science, University of Minnesota, Minneapolis 55455, USA.

出版信息

J Hematother. 1996 Oct;5(5):475-83. doi: 10.1089/scd.1.1996.5.475.

DOI:10.1089/scd.1.1996.5.475
PMID:8938519
Abstract

Large-scale ex vivo expansion of human natural killer (NK) cells for adoptive immunotherapy requires assurance of good manufacturing practices. However, maximal expansion of NK is also desired to facilitate clinical trials with large numbers of IL-2-activated NK (ANK). A closed-system stirred-tank bioreactor is amenable to computer control of culture variables, thereby reducing the risk of contamination. We demonstrate that NK cultured in 250-ml spinner flasks expand 2.5-fold more than NK cultured in stationary tissue culture wells. We further show that during 33 days of culture, it is feasible to control the pH between 7.0 and 7.2 and the dissolved oxygen concentration at 40% of air saturation via direct on-line computer control in a 750-ml stirred-tank bioreactor. On-line measurement of optical density by a laser turbidity sensor, as a measure of cell concentration, correlated well with actual cell count data. NK expansion in the 750-ml bioreactor was 7-fold greater than in stationary tissue culture controls and 3-fold greater than in spinner flask controls. Consumption rates of glucose and oxygen and the production rate of lactate were measured and will be used to develop a nutrient feeding strategy to convert the batch reactor experiment into closed-system fed-batch or continuous flow modes. Computer-controlled stirred-tank bioreactors may facilitate clinical trials with high-purity ANK populations for adoptive immunotherapy.

摘要

为进行过继性免疫治疗而对人自然杀伤(NK)细胞进行大规模体外扩增需要确保良好生产规范。然而,也希望NK能实现最大程度的扩增,以推动针对大量白细胞介素2激活的NK(ANK)细胞的临床试验。封闭式搅拌罐生物反应器适合对培养变量进行计算机控制,从而降低污染风险。我们证明,在250毫升转瓶中培养的NK细胞比在静止组织培养孔中培养的NK细胞扩增了2.5倍。我们进一步表明,在33天的培养过程中,通过在750毫升搅拌罐生物反应器中进行直接在线计算机控制,将pH值控制在7.0至7.2之间,并将溶解氧浓度控制在空气饱和度的40%是可行的。通过激光浊度传感器在线测量光密度作为细胞浓度的指标,与实际细胞计数数据相关性良好。在750毫升生物反应器中NK细胞的扩增比静止组织培养对照高7倍,比转瓶对照高3倍。测量了葡萄糖和氧气的消耗速率以及乳酸的产生速率,并将用于制定营养物进料策略,将分批反应器实验转换为封闭式补料分批或连续流动模式。计算机控制的搅拌罐生物反应器可能有助于针对过继性免疫治疗的高纯度ANK细胞群体进行临床试验。

相似文献

1
Production of human natural killer cells for adoptive immunotherapy using a computer-controlled stirred-tank bioreactor.使用计算机控制的搅拌罐生物反应器生产用于过继性免疫疗法的人类自然杀伤细胞。
J Hematother. 1996 Oct;5(5):475-83. doi: 10.1089/scd.1.1996.5.475.
2
Clinical-grade, large-scale, feeder-free expansion of highly active human natural killer cells for adoptive immunotherapy using an automated bioreactor.临床级、大规模、无饲养层扩增高活性人自然杀伤细胞,用于采用自动化生物反应器的过继免疫疗法。
Cytotherapy. 2010 Dec;12(8):1044-55. doi: 10.3109/14653249.2010.504770. Epub 2010 Aug 26.
3
Ex vivo expansion of the highly cytotoxic human natural killer-92 cell-line under current good manufacturing practice conditions for clinical adoptive cellular immunotherapy.在现行良好生产规范条件下,对高细胞毒性的人自然杀伤细胞92细胞系进行体外扩增,用于临床过继性细胞免疫治疗。
Cytotherapy. 2003;5(3):259-72. doi: 10.1080/14653240310001523.
4
Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.源自体外扩增和激活的脐血单个核细胞的自然杀伤细胞和自然杀伤样T细胞的特性:对过继性细胞免疫治疗的意义
Exp Hematol. 2009 Oct;37(10):1216-29. doi: 10.1016/j.exphem.2009.07.009. Epub 2009 Jul 26.
5
Selection and expansion of natural killer cells for NK cell-based immunotherapy.用于基于自然杀伤细胞的免疫疗法的自然杀伤细胞的选择与扩增。
Cancer Immunol Immunother. 2016 Apr;65(4):477-84. doi: 10.1007/s00262-016-1792-y. Epub 2016 Jan 25.
6
Large scale ex vivo expansion and activation of human natural killer cells for autologous therapy.用于自体治疗的人自然杀伤细胞的大规模体外扩增与激活。
Bone Marrow Transplant. 1994 Oct;14(4):555-62.
7
Large-scale expansion of cytomegalovirus-specific cytotoxic T cells in suspension culture.巨细胞病毒特异性细胞毒性T细胞在悬浮培养中的大规模扩增。
Biotechnol Bioeng. 2004 Jan 20;85(2):138-46. doi: 10.1002/bit.10801.
8
Development of a clinical model for ex vivo expansion of multiple populations of effector cells for adoptive cellular therapy.用于过继性细胞治疗的多种效应细胞群体体外扩增临床模型的开发。
Cytotherapy. 2008;10(1):30-7. doi: 10.1080/14653240701762398.
9
A xenogeneic-free bioreactor system for the clinical-scale expansion of human mesenchymal stem/stromal cells.一种用于临床规模扩增人间充质干/基质细胞的无异种生物反应器系统。
Biotechnol Bioeng. 2014 Jun;111(6):1116-27. doi: 10.1002/bit.25187. Epub 2014 Feb 4.
10
Cellular immunotherapy of malignancies using the clonal natural killer cell line NK-92.使用克隆性自然杀伤细胞系NK-92对恶性肿瘤进行细胞免疫治疗。
J Hematother Stem Cell Res. 2001 Aug;10(4):535-44. doi: 10.1089/15258160152509145.

引用本文的文献

1
Scalable production process development for NK cells targeting large-scale expansion.用于靶向大规模扩增的自然杀伤细胞的可扩展生产工艺开发。
Regen Ther. 2025 Aug 5;30:535-543. doi: 10.1016/j.reth.2025.07.014. eCollection 2025 Dec.
2
Recent Advances in the Development of Bioreactors for Manufacturing of Adoptive Cell Immunotherapies.用于制造过继性细胞免疫疗法的生物反应器开发的最新进展
Bioengineering (Basel). 2022 Dec 15;9(12):808. doi: 10.3390/bioengineering9120808.
3
Current Perspectives on "Off-The-Shelf" Allogeneic NK and CAR-NK Cell Therapies.
异体来源的自然杀伤 (NK) 细胞和嵌合抗原受体 NK (CAR-NK) 细胞疗法的最新观点。
Front Immunol. 2021 Dec 1;12:732135. doi: 10.3389/fimmu.2021.732135. eCollection 2021.
4
Lymphocyte expansion in bioreactors: upgrading adoptive cell therapy.生物反应器中的淋巴细胞扩增:提升过继性细胞疗法
J Biol Eng. 2021 Apr 13;15(1):13. doi: 10.1186/s13036-021-00264-7.
5
Beyond CAR T Cells: Other Cell-Based Immunotherapeutic Strategies Against Cancer.超越嵌合抗原受体T细胞:其他基于细胞的癌症免疫治疗策略
Front Oncol. 2019 Apr 10;9:196. doi: 10.3389/fonc.2019.00196. eCollection 2019.
6
Shaping of Natural Killer Cell Antitumor Activity by Cultivation.通过培养塑造自然杀伤细胞的抗肿瘤活性
Front Immunol. 2017 Apr 26;8:458. doi: 10.3389/fimmu.2017.00458. eCollection 2017.
7
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity.基于自然杀伤细胞的癌症治疗:获得并维持抗肿瘤活性的可能策略。
Front Immunol. 2015 Nov 30;6:605. doi: 10.3389/fimmu.2015.00605. eCollection 2015.
8
A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer.异体自然杀伤细胞治疗复发性卵巢癌和乳腺癌的 II 期研究。
Cytotherapy. 2011 Jan;13(1):98-107. doi: 10.3109/14653249.2010.515582. Epub 2010 Sep 20.
9
Expansion of mouse sertoli cells on microcarriers.微载体上的小鼠支持细胞的扩增。
Cell Prolif. 2010 Jun;43(3):275-86. doi: 10.1111/j.1365-2184.2010.00677.x.
10
Design, characterization and application of a minibioreactor for the culture of human hematopoietic cells under controlled conditions.设计、表征和应用一种小型生物反应器,以在控制条件下培养人造血细胞。
Cytotechnology. 1998 Nov;28(1-3):127-38. doi: 10.1023/A:1008042000744.